Account

Obstetrics and gynecology international, 2014(4), 795329, 2014

Subcutaneous Terbutaline Pump for Maintenance of Tocolysis following Arrest of Acute Preterm Labor

Kalpana Singh , Mohammed T. Ansari , Laura Gaudet

Author affiliations (3)
  • Hamad Medical Corporation ROR
  • Clinical Epidemiology Program, the Ottawa Hospital Research Institute, P.O. Box 201B, TOH-General Campus, 501 Smyth Rd, Ottawa, ON, Canada K1H 8L6
  • Horizon Health Network ROR
DOI10.1155/2014/795329 PMID24799909
Read at source

Abstract not indexed. Read at source

Topics

Pregnancy
terbutaline tocolysis pump, maintenance tocolysis preterm labor, subcutaneous terbutaline infusion, preterm labor arrest management, beta-agonist tocolytic therapy, preterm birth prevention, gestational age prolongation, tocolysis maintenance therapy, systematic review tocolysis, subcutaneous pump preterm labor
PMID 24799909 24799909 DOI 10.1155/2014/795329 10.1155/2014/795329

Cite this article

Jelsema, R. D. (1998). Subcutaneous terbutaline pump. *The Journal of Reproductive Medicine*, *43*(4), 401-402.

Keywords

Contraindications, Female, Humans, Infusion Pumps, Injections, Subcutaneous, Maternal Mortality, Obstetric Labor, Premature/drug Therapy, Pregnancy, Risk Factors, Terbutaline/adverse Effects, Tocolytic Agents/adverse Effects, Twins, Tocolytic Agents, Terbutaline

Related articles

Learn

Resources

Tools

Help

Candid Platinum Transparency 2026

RRM Academy is a 501(c)(3) nonprofit providing free and low-cost education in restorative reproductive medicine for patients and healthcare professionals.

This site is an educational resource and does not provide medical advice. Inclusion of a study does not imply endorsement of its findings. Always consult a qualified healthcare provider for diagnosis and treatment.

© 2026 RRM Academy · All Rights Reserved

Restorative Reproductive Medicine Foundation Inc. · 3401 Hartzdale Dr, Ste 103B PMB 3518, Camp Hill, PA 17011 · EIN: 93-4594315
AI Instructions Terms of Use Medical Disclaimer Privacy Policy